Antiepileptic therapy with phenytoin: which is the optimum serum level?

Serum T3 level in the patients with hyperthyroidism after therapy.

Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum.

Letter: Serum-phenytoin levels.

Monitoring serum-phenytoin.

Serum phenytoin after Ethosuximide.

Is the level of maternal serum prohepcidin associated with preeclampsia?

The serum uromodulin level is associated with kidney function.

Impact of cytochrome P450 inducers with or without inhibitors on the serum clobazam level in patients with antiepileptic polypharmacy.

Late-onset thrombocytopenia with phenytoin therapy.

Torsades de pointes therapy with phenytoin.

Serum-phenytoin, seizures, and electroencephalography.

Mechanochemical preparation of hydantoins from amino esters: application to the synthesis of the antiepileptic drug phenytoin.

Increased serum resistin level is associated with coronary heart disease.

The optimum illuminance level for clinical electro-oculography.

Diagnosing appendicitis with serum bilirubin level: Is there any problem?

Teratogenic activity of the antiepileptic drugs phenobarbital, phenytoin, and primidone in mice.

Decreased phenytoin level after carboplatin treatment.

The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis.

Effect of physical training on aerobic capacity, seizure occurrence, and serum level of antiepileptic drugs in adults with epilepsy.

Increase in serum cholesterol during phenytoin treatment.

Serum-phenytoin levels in management of epilepsy.

Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis.

Antiepileptic drug therapy in patients with autoimmune epilepsy.

Optimum antihypertensive therapy: does adiposity matter?

Suggest Documents

Serum T3 level in the patients with hyperthyroidism after therapy.

Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum.

Letter: Serum-phenytoin levels.

Monitoring serum-phenytoin.

Serum phenytoin after Ethosuximide.

Is the level of maternal serum prohepcidin associated with preeclampsia?

The serum uromodulin level is associated with kidney function.

Impact of cytochrome P450 inducers with or without inhibitors on the serum clobazam level in patients with antiepileptic polypharmacy.

Late-onset thrombocytopenia with phenytoin therapy.

Torsades de pointes therapy with phenytoin.

Serum-phenytoin, seizures, and electroencephalography.

Mechanochemical preparation of hydantoins from amino esters: application to the synthesis of the antiepileptic drug phenytoin.

Increased serum resistin level is associated with coronary heart disease.

The optimum illuminance level for clinical electro-oculography.

Diagnosing appendicitis with serum bilirubin level: Is there any problem?

Teratogenic activity of the antiepileptic drugs phenobarbital, phenytoin, and primidone in mice.

Decreased phenytoin level after carboplatin treatment.

The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis.

Effect of physical training on aerobic capacity, seizure occurrence, and serum level of antiepileptic drugs in adults with epilepsy.

Increase in serum cholesterol during phenytoin treatment.

Serum-phenytoin levels in management of epilepsy.

Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis.

Antiepileptic drug therapy in patients with autoimmune epilepsy.

Optimum antihypertensive therapy: does adiposity matter?

Antiepileptic therapy with phenytoin: which is the optimum serum level?

Recommend Documents

Follow Us